Site Search
Mayo Clinic Laboratory and Pathology Research Roundup: January 9 - Insights
This week's research roundup feature: To describe a 41-year-old woman with a history of neonatal onset multisystem inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor...
Mayo Clinic Laboratory and Pathology Research Roundup: January 2 - Insights
This week's research roundup feature: Sarcomas are a recently identified group of undifferentiated round/spindle cell neoplasms with a predilection for the head and neck region.
Mayo Clinic Laboratory and Pathology Research Roundup: January 30 - Insights
This week's research roundup feature: Incapacitated regulatory T cells (Tregs) contribute to immune-mediated diseases. Inflammatory Tregs are evident during human inflammatory bowel disease (IBD); however, mechanisms driving the development...
Mayo Clinic Laboratory and Pathology Research Roundup: December 19 - Insights
This week's research roundup feature: R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest...
Mayo Clinic Laboratory and Pathology Research Roundup: January 23 - Insights
This week's research roundup feature: Measles virus (MV) vaccine strains have shown significant preclinical antitumor activity against glioblastoma (GBM), the most lethal glioma histology. In this first in human trial (NCT00390299), a...
Mayo Clinic Laboratory and Pathology Research Roundup: January 16 - Insights
This week's research roundup feature: Understanding the incidence, causes, and trends of sudden cardiac death (SCD) among young competitive athletes is critical to inform preventive policies.
Mayo Clinic Laboratory and Pathology Research Roundup: February 6 - Insights
This week's research roundup feature: Powassan virus (POWV) is an emerging arthropod-borne flavivirus, transmitted by Ixodes spp. ticks, which has been associated with neuroinvasive disease and poor outcomes.
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.
MASTERMIND: A Smarter Search for Microbial Diagnostics - Insights
In the war against microbes, human beings are vastly outnumbered—and losing the weapons race.
MCL @Work: Tamara Staley - Insights
Eight years ago, Tamara Staley joined Mayo Clinic Laboratories’ Cardiovascular Sales team selling CV diagnostic testing to community hospitals. Now, she leads sales for Hematology and Oncology’s Central Region. Tamara is proud to help...
MCL @Work: Brie LaJoye - Insights
Brie LaJoye began her career with Mayo Clinic in 2018 as an intern and has been with the organization for nearly six years. She currently works as a Laboratory information system (LIS) technical specialist, managing lab instrumentation,...
MCL @Work: Sarah Mason - Insights
In her current role as senior manager for global logistics at Mayo Clinic Laboratories, Sarah Mason oversees the coordination of patient sample shipments by working with a network of stakeholders, couriers, carriers, and vendors. Sarah...
New research by Robin Patel, M.D. and others at Mayo Clinic has found that the use of a “transcriptomic-based cellular deconvolution tool” called CIBERSORTx could help improve the detection of infectious and non-infectious causes of failed...
Global Industry Activities: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss...
Autoimmune Epilepsy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune epilepsy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy - Insights
In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses various clinical and paraclinical features of autoimmune encephalitis, autoimmune seizures, and...
Myasthenia Gravis Testing - Mayo Clinic Laboratories
Our diagnostic algorithms consist of tests that are always performed, and then additional testing is performed depending on the initial results.
Neuropathies - Mayo Clinic Laboratories
Our comprehensive approach evaluates specific antibodies associated with autoimmune or paraneoplastic neuropathies offering answers for patients.
Biopharma only testing - Insights
Find out how our suite of BioPharma Diagnostics-specific neurology testing can provide answers for your patients.
Reframing diagnosis for peripheral neuropathy - Insights
Learn more about how Mayo Clinic Laboratories’ algorithmic testing approach to peripheral neuropathy cuts through diagnostic complexity to provide meaningful answers.
Autoimmune Movement Disorders - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune movement disorders contain clinically relevant antibodies providing accurate answers for treatment guidance.
Hereditary Alzheimer's disease and dementia - Insights
Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.
See how our innovative evaluations detect multiple sclerosis with increased sensitivity to put patients on the correct diagnostic pathway.
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Insights
In this month's "Hot Topic," Eoin Flanagan, M.B., B.Ch., reviews the recent diagnostic criteria for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD).
Multiple Sclerosis Profile Updates - Insights
Maria Alice Willrich, Ph.D., explains kappa free light chain testing — Mayo Clinic Laboratories' data-driven approach to diagnose multiple sclerosis. The automated assay is more sensitive, cost-effective, and faster than traditional...
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
Autoimmune Myelopathy Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis.
Autoimmune Dementia Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune dementia contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune encephalopathy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
The Power of Discovery: Mayo Clinic Laboratories Autoimmune Neurology Service - Insights
Autoimmune neurological disorders can often be treated, sometimes with full restoration of function. However, because the symptoms mimic other conditions, autoimmune neurological disorders are frequently misdiagnosed, resulting in an...
Autoimmune testing education - Insights
Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research labs, clinical labs, and Autoimmune Neurology Clinic, we have developed panels customized to address specific...
Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Learn more about how carrier screening at Mayo Clinic Laboratories can provide prospective parents with a personalized risk assessment of bearing a child with certain inherited conditions.
Frequently asked questions - Insights
Read answers to frequently asked questions about prenatal testing at Mayo Clinic Laboratories, including specimen requirements, maternal cell contamination testing, pricing, and more.
Learn more about Mayo Clinic Laboratories testing for pregnancy loss, which can help determine causes and risk of recurrence for future pregnancies.
MCL @Work: Robin Huiras-Carlson - Insights
Robin Huiras-Carlson's connection with Mayo Clinic traces back to her early years, marked by a diagnosis of a rare genetic condition at the age of 10. Today, as a senior marketing specialist with Mayo Clinic Laboratories, she draws...
Purine and pyrimidine metabolism disorders - Insights
Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.
November 2023 - Clinical Informatics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Informatics.
October 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
October 2023 - Gynecological Pathology and Surgical Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Gynecological Pathology and Surgical Pathology.
Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt...
COVID-19 weekly news: May 16-22 2022 - Insights
Topics include: COVID-19 update, tips for navigating a return to work with long COVID, and COVID-19 booster vaccinations extended to kids 5-11.
Week in Review: June 3 - Insights
Today's highlights include: Spread of monkeypox underscores need for physicians to be ready to understand, Pfizer completes application to FDA for vaccine for children under 5, and connect is key to supporting multiple sclerosis patients.
Week in Review: May 20 - Insights
Today's highlights include: US at risk of COVID-19 drug shortages this summer, Rochester startup Vyriad developing cancer-fighting viruses, and CDC expresses concern about possibility of undetected monkeypox spread in U.K.
Using Data-Driven, In-Person Discussions to Support Outreach Clients - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton. They...
Mayo Clinic Laboratory and Pathology Research Roundup: February 20 - Insights
This week's research roundup feature: Patients with dementia with Lewy bodies (DLB) may have Alzheimers disease (AD) pathology that can be detected by plasma biomarkers. Our objective was to evaluate plasma biomarkers of AD and their...
Mayo Clinic Laboratory and Pathology Research Roundup: February 13 - Insights
This week's research roundup feature: VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, caused by somatic mutations in UBA1, is an autoinflammatory disorder with diverse systemic manifestations. Thrombosis is a...
Cayuga Medical Center and Mayo Clinic Laboratories - Insights
A world-class investment Collaboration resulting in world-class, value-based patient care Achieving greatness for yourself and your patients
A novel testing approach for newly identified VEXAS syndrome - Insights
VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...
COVID-19: The pandemic that's forever changed laboratory testing - Insights
Since March 2020, the COVID-19 pandemic has had a lasting impact on the lives of millions of people around the world, including the many brave health care workers who risked their own health to provide lifesaving care to those infected by...